日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma

阿达沃塞替尼联合放疗和替莫唑胺治疗新诊断胶质母细胞瘤的I期研究及复发性胶质母细胞瘤的肿瘤内药物浓度

Lee, Eudocia Q; Alexander, Brian M; Romo, Carlos G; Supko, Jeffrey G; Agar, Nathalie Y R; Talebi, Zahra; Ahluwalia, Manmeet S; Desai, Arati S; Dietrich, Jorg; Kaley, Thomas J; Peereboom, David M; Gantchev, Jennifer; Baquer, Gerard; Santagata, Sandro; Takebe, Naoko; Desideri, Serena; Fisher, Joy D; Sims, Megan; Ye, Xiaobu; Ligon, Keith L; Nabors, Louis B; Grossman, Stuart A; Wen, Patrick Y

First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies.

首次对 Epstein-Barr 阳性鼻咽癌患者进行小分子 EBNA1 抑制剂 VK-2019 的人体临床试验,并进行药代动力学和药效学研究

Colevas A Dimitrios, Talebi Zahra, Winters Elizabeth, Even Caroline, Lee Victor Ho-Fun, Gillison Maura L, Khan Saad A, Lu Rong, Pinsky Benjamin A, Soldan Samantha S, Vladmirova Olga, Lieberman Paul M, Messick Troy E

Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial.

恩替诺特、纳武利尤单抗和伊匹木单抗治疗晚期 HER2 阴性乳腺癌女性:一项 Ib 期试验

Roussos Torres Evanthia T, Ho Won J, Danilova Ludmila, Tandurella Joseph A, Leatherman James, Rafie Christine, Wang Chenguang, Brufsky Adam, LoRusso Patricia, Chung Vincent, Yuan Yuan, Downs Melinda, O'Connor Ashley, Shin Sarah M, Hernandez Alexei, Engle Elizabeth L, Piekarz Richard, Streicher Howard, Talebi Zahra, Rudek Michelle A, Zhu Qingfeng, Anders Robert A, Cimino-Mathews Ashley, Fertig Elana J, Jaffee Elizabeth M, Stearns Vered, Connolly Roisin M

Transforming Growth Factor Beta 2 (TGFB2) and Interferon Gamma Receptor 2 (IFNGR2) mRNA Levels in the Brainstem Tumor Microenvironment (TME) Significantly Impact Overall Survival in Pediatric DMG Patients

脑干肿瘤微环境(TME)中转化生长因子β2(TGFB2)和干扰素γ受体2(IFNGR2)mRNA水平显著影响儿童弥漫性中脑胶质瘤患者的总生存期

Qazi, Sanjive; Talebi, Zahra; Trieu, Vuong

Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen

利用竞争性逆流筛选法系统评价酪氨酸激酶抑制剂作为 OATP1B1 底物的性能

Drabison, Thomas; Boeckman, Mike; Yang, Yan; Huang, Kevin M; de Bruijn, Peter; Nepal, Mahesh R; Silvaroli, Josie A; Chowdhury, Anika T; Eisenmann, Eric D; Cheng, Xiaolin; Pabla, Navjotsingh; Mathijssen, Ron H J; Baker, Sharyn D; Hu, Shuiying; Sparreboom, Alex; Talebi, Zahra

Tumoricidal properties of thymoquinone on human colorectal adenocarcinoma cells via the modulation of autophagy

百里香醌通过调节自噬对人类结肠直肠腺癌细胞的杀肿瘤特性

Mohammad Saleh Moulana, Sanya Haiaty, Ahad Bazmani, Roya Shabkhizan, Marziyeh Sadat Moslehian, Fatemeh Sadeghsoltani, Mostafa Mostafazadeh, Mohammad Reza Asadi, Mehdi Talebi, Zahra Jafari, Mohammad Reza Morovati, Mohammad Hosein Farzaei #, Reza Rahbarghazi #

Prevalence of anemia and its associated factors among patients with type 2 diabetes mellitus in a referral diabetic clinic in the north of Iran

伊朗北部一家糖尿病专科诊所2型糖尿病患者贫血患病率及其相关因素

Hizomi Arani, Reyhane; Fakhri, Farima; Naeimi Tabiee, Mohammad; Talebi, Fatemeh; Talebi, Zahra; Rashidi, Negin; Zahedi, Maryam

The Effects of 3-Month Rosuvastatin Adjuvant Therapy on Post Thrombotic Syndrome following Deep Vein Thrombosis; a Randomized Clinical Trial

瑞舒伐他汀辅助治疗3个月对深静脉血栓后综合征的影响:一项随机临床试验

Pishgahi, Mehdi; Ghane Fard, Shirin; Lak Tabriz, Rahil; Karimi Toudeshki, Kimia; Talebi, Zahra

Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination

抗真菌药物与CYP3A和OATP1B介导的维奈托克消除的相互作用

Eisenmann, Eric D; Garrison, Dominique A; Talebi, Zahra; Jin, Yan; Silvaroli, Josie A; Kim, Jin-Gyu; Sparreboom, Alex; Savona, Michael R; Mims, Alice S; Baker, Sharyn D

Boosting the oral bioavailability of anticancer drugs through intentional drug-drug interactions

通过有意设计的药物相互作用来提高抗癌药物的口服生物利用度。

Eisenmann, Eric D; Talebi, Zahra; Sparreboom, Alex; Baker, Sharyn D